酸化-炎症性クロストラックと多標的天然剤:糖尿病血管合併症の解読

Jingwen Liu¹, Kexin Li¹, Zixin Yi¹

¹School of Life Science, Inner Mongolia University, Hohhot 010020, China.

Current issues in molecular biology

|August 27, 2025

まとめ

酸化ストレスや炎症に起因する糖尿病の血管の合併症と闘うために自然な製品は多目的のアプローチを提供しますこれらの有望な天然薬の臨床応用にはさらなる研究が必要です

科学分野:

生物医学
薬理学について
糖尿病について

背景:

糖尿病 (DM) は世界的に蔓延する健康問題です
慢性高血糖症は重篤な合併症,特に糖尿病性血管病変を引き起こす.
酸化ストレスと炎症はこれらの血管疾患の主な要因です

研究の目的:

糖尿病の血管損傷を誘発する病理的経路を体系的に検討する.
DMの合併症の管理における天然製品の多標的治療の可能性を探求する.
自然製品の臨床翻訳における課題を特定する.

主な方法:

糖尿病血管疾患のメカニズムに関する文献の体系的なレビュー
代謝不調,ミトコンドリア機能不全,ERストレス,表遺伝子などの病理学的経路の分析.
単一標的の合成薬物と比べると自然製品の多標的の相乗効果の評価

主要な成果:

高血糖症による酸化ストレスと炎症は糖尿病の血管病変をシネージー的に誘発する.
複数の経路 (代謝経路,ミトコンドリア経路,ER経路,表遺伝経路) が収束し,これらの病理を促進する.
自然製品は多標的効果を示し,酸化還元バランスを回復し,炎症を抑制します.

結論:

天然製品は多標的作用により糖尿病性血管疾患の治療策として有望である.
血管機能を改善し病原性ネットワークを調節することで疾患の進行を遅らせることができます
厳格なメカニズム研究と検証は自然製品の臨床翻訳に不可欠です

キーワード:

糖尿病糖尿病炎症多標的療法自然産物酸化ストレス血管の合併症

さらに関連する動画

05:51

Characterization of a Novel Human Organotypic Retinal Culture Technique

Published on: June 9, 2021

4.1K

07:33

Visualization of Vascular Ca2+ Signaling Triggered by Paracrine Derived ROS

Published on: December 21, 2011

15.6K

関連する概念動画

01:20

Pathophysiology of Diabetes

1.2K

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...

1.2K

01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

01:15

Diabetes: Management and Pharmacotherapy

354

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

354

01:30

Inflammatory Response I: Vascular and Cellular

12.4K

The inflammatory response is the body's defense against infection, injury, or irritation from bacteria, trauma, toxins, or heat. Inflammation helps locate and destroy pathogens and remove damaged tissue elements to heal the body. During this initial phase, fluid, blood products, and nutrients migrate to the injured area, resulting in redness, heat, swelling, ache, and loss of function. Moreover, signs of systemic inflammation include fever, increased WBC count, malaise, anorexia, nausea,...

12.4K

01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

2.9K

01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

関連する実験動画